Drugs / Esomeprazol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02355236 | Feb → Dec 2015 | osteoarthritis | Severance Hospital | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03315676 Comparator | Nov 2017 → Nov 2022 | ulcer disease | Shinshu University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Esomeprazol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03315676 ↗ |
| Action | Inhibit | “a proton pump inhibitor” NCT02355236 ↗ |
| Route | Oral | “oral Esomeprazol” NCT03315676 ↗ |